illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Euglena
Company logo

Euglena | Sustainability Performance

https://www.euglena.jp/
Linkedin

Specializes in biotechnology involving algae-based products for health, cosmetics, and sustainable energy.

2005

Japan

501 - 1,000 employees

Biotechnology

$100M - 500M in revenue

$10M - 25M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#9305
Overall
#400
in Japan
#200
in Biotechnology

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Governance
TargetsESG scores and exclusionsB-corp & CDP
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Rici Healthcare

Japan, Hospital & Health Care, Hospital & Health Care


Company logo
Santen Pharmaceutical

Japan, Hospital & Health Care, Pharmaceuticals


Company logo
Takeda Pharmaceutical

Japan, Hospital & Health Care, Pharmaceuticals

Market cap

7.3T $, 2026▼29% YoY

Revenue

336.6M $, 2025▲5.5% YoY

R&D intensity

0% 2025

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

7.3T $, 2026▼29% YoY

Revenue

336.6M $, FY2025▲5.5% YoY

EBITDA

20.9M $, FY2025▼9.1% YoY

Operating margin

6% Industry: -370▲89.8% YoY

Revenue & EBITDA

$336.6MFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

30.7M 2025▼9.8% YoY

Capex

4.0M 2025▼23% YoY

Debt/equity ratio

0.9 Industry: 2▼NaN% YoY

R&D intensity

0.0%FY2025

R&D as % of revenue

R&D as % of revenue
Industry benchmark

Powered by illuminem

Return on invested capital

-1.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.3

▲ 2.5%

2023

0.3

▼ 10.5%

2024

0.3

▲ 4.3%

2025

57.4

2030

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Not available

Recycling policy

Not available

Workplace health & safety policy

Not available

29%
Independent Directors

4 out of 14 incl. management

Powered by illuminem

Overall score

0

Environment

0

Social

0

Governance

0

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

CDP Scores


Climate Score

Not disclosed

Forests Score

Not disclosed

Water Score

Not disclosed

A

A-

B

B-

C

C-

D

D-

Powered by illuminem and GIST impact

Reporting

sustainability report symbol

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees


Total sustainability employees

4-6


    Available in
    Scale package

    Access
  • Email

  • Email